Transforming growth factor-beta 1 null mice. An animal model for inflammatory disorders
about
Medical Therapy of Fibrostenotic Crohn's DiseaseTGF-β1/Smads and miR-21 in Renal Fibrosis and InflammationReduced tumor necrosis factor-alpha and transforming growth factor-beta1 expression in the lungs of inbred mice that fail to develop fibroproliferative lesions consequent to asbestos exposureTransforming growth factor-β1 receptor inhibition preserves glomerulotubular integrity during ureteral obstruction in adults but worsens injury in neonatal miceSynergy of Transforming Growth Factor Beta 1 and All Trans Retinoic Acid in the Treatment of Inflammatory Bowel Disease: Role of Regulatory T cells.Mechanisms of intestinal inflammation and development of associated cancers: lessons learned from mouse models.Medical therapy of stricturing Crohn's disease: what the gut can learn from other organs - a systematic review.Inhibition of proinflammatory RANTES expression by TGF-beta1 is mediated by glycogen synthase kinase-3beta-dependent beta-catenin signalingStat4 is critical for the balance between Th17 cells and regulatory T cells in colitisEffects of cold atmospheric plasma (CAP) on ß-defensins, inflammatory cytokines, and apoptosis-related molecules in keratinocytes in vitro and in vivoMechanisms of Intestinal Serotonin Transporter (SERT) Upregulation by TGF-β1 Induced Non-Smad PathwaysInflammatory bowel disease in C.B-17 scid mice reconstituted with the CD45RBhigh subset of CD4+ T cells.Transforming growth factor beta signaling in adult cardiovascular diseases and repair.Transforming growth factor-β1 regulates Cdk5 activity in primary sensory neurons.The immune-stimulating peptide WKYMVm has therapeutic effects against ulcerative colitis.Transforming growth factor-beta 3 is required for secondary palate fusion.Inhibition of VEGF or TGF-{beta} signaling activates endothelium and increases leukocyte rolling.Perspectives of TGF-β inhibition in pancreatic and hepatocellular carcinomas.Regulatory T-cell vaccination independent of auto-antigen.Working out mechanisms of controlled/physiologic inflammation in the GI tract.Animal models of intestinal fibrosis: new tools for the understanding of pathogenesis and therapy of human disease.Transforming growth factor-beta synthesis by human peritoneal mesothelial cells. Induction by interleukin-1Smad4 deficiency in T cells leads to the Th17-associated development of premalignant gastroduodenal lesions in mice.Mechanisms, Management, and Treatment of Fibrosis in Patients With Inflammatory Bowel Diseases.TGF-beta1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II.TGF-beta1 Inhibits TLR-mediated odontoblast responses to oral bacteria.Pro-Inflammatory Signaling by IL-10 and IL-22: Bad Habit Stirred Up by Interferons?TGFbeta neutralization within cardiac allografts by decorin gene transfer attenuates chronic rejection.Redirecting TGF-β Signaling through the β-Catenin/Foxo Complex Prevents Kidney Fibrosis.DMSO Enhances TGF-β Activity by Recruiting the Type II TGF-β Receptor From Intracellular Vesicles to the Plasma Membrane.Intestinal Fibrosis and Liver Fibrosis: Consequences of Chronic Inflammation or Independent Pathophysiology?Established and novel pathophysiological mechanisms of pericardial injury and constrictive pericarditis
P2860
Q26777724-96AF73E8-591A-4868-9B59-F4B02F5AAFF6Q28067425-B0C73E75-B897-40AB-92D0-30E1D11B5F2EQ28395678-8FD66D3E-7CA0-41B7-9437-1CD420F528E1Q30414456-99A8210B-B497-4121-BBC4-7BCCC6622B24Q33772861-5B05D689-7AD0-45FF-8D49-359EBF83FFA0Q33886458-A4AD3F6A-1372-413C-ADDF-8EC94A2C817DQ34504710-D3D82F9F-6255-4B5D-9AFC-B82CFD10EB99Q34606146-29144F32-C67A-4A48-80E9-516EDB212357Q34995567-3A8B2ADB-CA9C-4C6D-885D-CA4809D4229CQ35175838-E798B0DA-19C6-4BC3-B2F5-4788419C444AQ35625107-5371BF03-5168-4F78-89D5-A6C23EBE3AFBQ35773643-8EDBA587-C726-4B2B-AFEB-4E12849FE898Q35895390-3B3450EF-BE33-4177-AD3F-4E8C99F80914Q35956465-72C00351-897B-4AC0-AD46-896C39F6680EQ37212182-01CFBD8E-F6CC-41C3-8E3D-2A95D5021053Q37373842-55BC453E-78CD-40A2-8E3A-5A32F2AAA60FQ37416913-EA3CF131-4434-4324-91A4-AB404AA2A97CQ37649636-1FAAA8BD-9B38-45EE-A958-0155708A13E8Q37679455-B3E81F27-4339-49CF-8B1D-605255AB3161Q37998914-287A8BE4-62D8-4A8E-A766-F5E2D12E6088Q38033380-59D1526E-8CA7-40E8-8AD5-59F3EE2899C0Q38358575-5D591E5C-26DB-4AFF-869B-B85239DC8271Q38732326-7BA7B2AC-90B4-4E26-A03F-875945ECCEDCQ38976561-0E84C0BC-AD51-41C3-B866-099B995620ECQ39737677-2EC66AAF-E126-468F-A80D-ED4D3F315403Q41810772-553B3461-6224-465D-8F68-B8D2054FA993Q41999154-A5A047A5-AA3D-405D-A2B8-FA27415DA1D7Q42639607-4588189D-1190-4741-A6C6-941C6A99E9A8Q47698363-0BE1CB3E-2A2E-4D6D-B5B1-8791F655EDBFQ55036249-89A0493C-98DC-46F6-8BAD-2ED942D0B70AQ55262881-03040767-CDCC-456F-9C4B-6EBF67D3E657Q57821348-095B3D69-4C00-4B6D-B3CF-9FEB0424AD5F
P2860
Transforming growth factor-beta 1 null mice. An animal model for inflammatory disorders
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Transforming growth factor-beta 1 null mice. An animal model for inflammatory disorders
@ast
Transforming growth factor-beta 1 null mice. An animal model for inflammatory disorders
@en
type
label
Transforming growth factor-beta 1 null mice. An animal model for inflammatory disorders
@ast
Transforming growth factor-beta 1 null mice. An animal model for inflammatory disorders
@en
prefLabel
Transforming growth factor-beta 1 null mice. An animal model for inflammatory disorders
@ast
Transforming growth factor-beta 1 null mice. An animal model for inflammatory disorders
@en
P2093
P2860
P1476
Transforming growth factor-beta 1 null mice. An animal model for inflammatory disorders
@en
P2093
A B Kulkarni
C L Mackall
S Karlsson
P2860
P304
P407
P577
1995-01-01T00:00:00Z